Letter: Beyond Financial Toxicity: Recognizing Financial Distress as Clinical Suffering in Advanced Cancer

Dear Editor:

We read with great interest the recent article by Tschanz et al. (2026) on financial distress in patients with advanced cancer. The study makes an important contribution by showing that high financial distress is common in supportive care settings and is associated with younger age, nonmarried status, greater symptom burden, and poorer quality of life. ¹ These findings suggest that financial distress is not peripheral to advanced cancer care but part of the illness experience itself.

What seems especially important, however, is that these findings may indicate more than measurable economic burden. Financial distress may also function as a form of clinical suffering that shapes how patients endure illness, interpret symptoms, and remain engaged with treatment. Recent work has described cancer-related financial toxicity as involving not only material hardship but also behavioral and psychological hardship, making it difficult to separate cost burden from mental health burden in real clinical life. ² From this perspective, financial distress enters the emotional world of illness as fear, uncertainty, guilt, and loss of control.

This broader reading matters because, once financial distress is understood as lived suffering, its clinical consequences become easier to see. Patients may delay visits, underreport symptoms, avoid supportive medications, or remain silent about affordability concerns in order to protect the therapeutic relationship. Recent evidence also continues to show that financial toxicity is closely linked to poorer health-related quality of life among people with cancer. ³ This suggests that financial distress is not merely a payment problem but also a psychological and clinical one.

For that reason, the response should be framed more explicitly as part of supportive and psychosocial cancer care rather than screening alone. Identifying distress is necessary, but insufficient if not followed by a humane care pathway. A more responsive model may include early identification, brief and empathetic cost of care conversations, and timely referral to social work, financial navigation, or mental health support when needed. Encouragingly, Wheeler et al. (2024) found that a comprehensive financial navigation intervention significantly improved perceived financial toxicity, with mean COST scores increasing from 6.4 to 13.3 after intervention. ⁴

We, therefore, respectfully suggest that future research move beyond prevalence estimates toward a more integrated account of how financial distress operates during serious illness. Longitudinal studies could clarify whether it contributes to worsening symptoms and psychological distress over time or whether these relationships are bidirectional. Mixed-method studies may also reveal how dignity, family responsibility, and uncertainty shape its lived meaning in advanced cancer. Most importantly, intervention studies should test whether outcomes improve when screening is paired with cost communication, financial navigation, and psychosocial care. In our view, the broader significance of this study is that it invites the field to recognize financial distress not only as a cost issue but also as a meaningful part of patients’ clinical and emotional suffering.